SCI Pharmtech Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	51.95	60.63	582.38	942.06	166.83	332.23
Trading Asset Securities	1.01	14.17	110.37	89	97.55	360.4
Cash & Short-Term Investments	52.96	74.8	692.76	1,031	264.37	692.63
Cash Growth	-89.64%	-89.20%	-32.81%	290.00%	-61.83%	9.42%
Accounts Receivable	331.63	247.93	289.51	307.37	173.57	82.98
Other Receivables	0.16	1.17	-	0.15	31.1	265.59
Receivables	331.79	249.1	289.51	307.52	204.67	348.56
Inventory	680.32	728.3	620.9	529.53	513.43	294.18
Other Current Assets	39.51	38.23	57.22	85.13	59.93	61.93
Total Current Assets	1,105	1,090	1,660	1,953	1,042	1,397
Property, Plant & Equipment	5,155	5,137	4,803	3,912	3,194	2,100
Long-Term Investments	220.9	187.05	237.52	241.62	208.04	124.97
Other Intangible Assets	27.56	29.65	37.77	46.15	54.58	60.29
Long-Term Deferred Tax Assets	161.56	161.56	143.82	153.28	167.25	241.55
Other Long-Term Assets	285.3	281.26	318.06	384.69	294.11	265.64
Total Assets	6,955	6,887	7,201	6,691	4,961	4,190
Accounts Payable	43.99	60.95	58.44	44.25	48.64	33.78
Accrued Expenses	-	60.3	99.04	110.72	128.35	121.46
Short-Term Debt	390	318.6	0.1	175	112	-
Current Portion of Long-Term Debt	-	360.11	403.44	20	-	-
Current Portion of Leases	5.66	5.62	2.47	1.95	0.83	1.58
Current Income Taxes Payable	51.37	42.89	85.25	11.54	3.86	-
Current Unearned Revenue	35.4	36.11	94.92	38.37	31.77	41.76
Other Current Liabilities	526.91	151.79	270.73	168.07	444.86	549.35
Total Current Liabilities	1,053	1,036	1,014	569.89	770.32	747.94
Long-Term Debt	300.4	258.39	578.01	842.67	432.36	-
Long-Term Leases	43.03	44.46	6.37	2.86	0.2	0.57
Long-Term Unearned Revenue	-	-	-	-	4.11	-
Pension & Post-Retirement Benefits	-	7.6	11.96	21.54	19.53	16.95
Long-Term Deferred Tax Liabilities	104.52	104.52	104.45	146	103.81	103.81
Other Long-Term Liabilities	42.93	41.02	8.68	7.84	1	-
Total Liabilities	1,544	1,492	1,724	1,591	1,331	869.26
Common Stock	1,195	1,195	1,195	1,195	953.82	953.82
Additional Paid-In Capital	2,235	2,235	2,235	2,234	1,357	1,348
Retained Earnings	1,988	1,968	2,037	1,646	1,373	1,067
Comprehensive Income & Other	-7.41	-3.44	10.07	25.46	-54.73	-48.93
Shareholders' Equity	5,411	5,394	5,477	5,100	3,629	3,321
Total Liabilities & Equity	6,955	6,887	7,201	6,691	4,961	4,190
Total Debt	739.09	987.18	990.39	1,042	545.38	2.16
Net Cash (Debt)	-686.13	-912.39	-297.63	-11.42	-281.01	690.48
Net Cash Growth	-	-	-	-	-	9.52%
Net Cash Per Share	-5.74	-7.62	-2.48	-0.10	-2.61	6.42
Filing Date Shares Outstanding	119.51	119.51	119.51	119.51	107.3	107.3
Total Common Shares Outstanding	119.51	119.51	119.51	119.51	107.3	107.3
Working Capital	51.26	54.05	646.01	1,383	272.08	649.37
Book Value Per Share	45.27	45.14	45.83	42.67	33.82	30.95
Tangible Book Value	5,383	5,365	5,439	5,054	3,575	3,260
Tangible Book Value Per Share	45.04	44.89	45.51	42.29	33.31	30.38
Land	-	687.88	687.88	687.88	687.88	825.68
Buildings	-	723.37	722.9	707	700.23	684.47
Machinery	-	2,510	2,467	1,786	1,185	577.08
Construction In Progress	-	2,452	1,965	1,565	1,323	633.3

Source: S&P Global Market Intelligence. Standard template. Financial Sources.